Evidence map›Paper›PMID 41190187›Full record

ReviewChemical science2025

Recent advances in mono- and multi-nuclear photoluminescent Cu(i) complexes with nitrogen containing ligands and their stimuli responsiveness.

Alessandra Forni, Daniele Malpicci, Elena Lucenti, Luca Zecchinello, Alessia Colombo, Elena Cariati

Abstract readReview
In one paragraph

Review in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessandra ForniInstitute of Chemical Sciences and Technologies ''Giulio Natta'' (SCITEC) of CNR Via Golgi 19 20133 Milano Italy.ORCID https://orcid.org/0000-0002-5020-5544
Daniele MalpicciInstitute of Chemical Sciences and Technologies ''Giulio Natta'' (SCITEC) of CNR Via Golgi 19 20133 Milano Italy.ORCID https://orcid.org/0000-0003-3397-2298
Elena LucentiInstitute of Chemical Sciences and Technologies ''Giulio Natta'' (SCITEC) of CNR Via Golgi 19 20133 Milano Italy.ORCID https://orcid.org/0000-0002-2418-7565
Luca ZecchinelloInstitute of Chemical Sciences and Technologies ''Giulio Natta'' (SCITEC) of CNR Via Golgi 19 20133 Milano Italy.ORCID https://orcid.org/0009-0008-0046-4020
Alessia ColomboDepartment of Chemistry, Università degli Studi di Milano Via Golgi 19 20133 Milano Italy daniele.malpicci@unimi.it elena.cariati@unimi.it.ORCID https://orcid.org/0000-0001-8004-3200
Elena CariatiInstitute of Chemical Sciences and Technologies ''Giulio Natta'' (SCITEC) of CNR Via Golgi 19 20133 Milano Italy.ORCID https://orcid.org/0000-0003-1781-0360

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Luminescent Cu(i)-derivatives represent a highly desirable alternative to their noble metal analogues in view of copper's relative abundance and low environmental concerns while maintaining large color tunability, high quantum yield and low photo-thermal lability. Moreover, the large variety of structural forms, spanning from 0D mononuclear to 3D polynuclear compounds characterized by peculiar emissive features, opens the door to an incredibly huge family of Cu(i) derivatives with potential application in many different fields. The present review focuses on luminescent neutral 0D mono-, di-, tri- and tetranuclear Cu(i) complexes with N-donor ligands developed during the period 2020 to mid-2025. After a general overview, specific sections are dedicated to members of each nuclearity. Emphasis is given to compounds' stimuli responsiveness, in particular towards vapour exposure and thermal and mechanical perturbations.

Identifiers

PMID41190187
PMCPMC12581026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.